Pages that link to "Q28109334"

The following pages link to The Patents-Based Pharmaceutical Development Process (Q28109334):

Displaying 26 items.

• Assessing implementation mechanisms for an international agreement on research and development for health products (Q22241277) (← links)
• Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder (Q24626017) (← links)
• Innovation in biomedicine: can stem cell research lead the way to affordability? (Q25256306) (← links)
• Enhancing the discovery and development of immunotherapies for cancer using quantitative and systems pharmacology: Interleukin-12 as a case study (Q28084489) (← links)
• Access to treatment for hepatitis C virus infection: time to put patients first (Q30248987) (← links)
• An iatrogenic pandemic of panic. (Q30353586) (← links)
• Forecasting drug utilization and expenditure in a metropolitan health region (Q33579584) (← links)
• Traversing the valley of death: a guide to assessing prospects for translational success (Q33887728) (← links)
• Ethics in practice: the state of the debate on promoting the social value of global health research in resource poor settings particularly Africa (Q34074948) (← links)
• Toward a definition of pharmaceutical innovation (Q34186669) (← links)
• The prince and the pauper. A tale of anticancer targeted agents (Q37042365) (← links)
• Economic return of clinical trials performed under the pediatric exclusivity program (Q37412752) (← links)
• Rethinking the responsiveness requirement for international research (Q37592748) (← links)
• Should financial incentives be used to differentially reward 'me-too' and innovative drugs? (Q37656190) (← links)
• The determinants of cost-effectiveness potential: an historical perspective on lipid-lowering therapies (Q39437437) (← links)
• Access to medicines, market failure and market intervention: a tale of two regimes (Q39541569) (← links)
• The lag time in initiating clinical testing of new drugs in combination with radiation therapy, a significant barrier to progress? (Q42547560) (← links)
• Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization. (Q42601375) (← links)
• Growth of the Asian health-care market: global implications for the pharmaceutical industry (Q44517803) (← links)
• Orphan drugs for rare diseases: is it time to revisit their special market access status? (Q44871497) (← links)
• US pharmaceutical innovation in an international context. (Q53175420) (← links)
• Australian Pharmaceutical Policy: Price Control, Equity, and Drug Innovation in Australia (Q57386355) (← links)
• Sepsis in the ICU: who needs progress? (Q64126912) (← links)
• Aligning pharmaceutical innovation with medical need (Q79888535) (← links)
• A dynamic perspective on pharmaceutical competition, drug development and cost effectiveness (Q85073175) (← links)
• Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making (Q89964214) (← links)